Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
1.840
+0.080 (4.55%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Annexon Employees
Annexon had 100 employees as of December 31, 2024. The number of employees increased by 29 or 40.85% compared to the previous year.
Employees
100
Change (1Y)
29
Growth (1Y)
40.85%
Revenue / Employee
n/a
Profits / Employee
-$1,382,000
Market Cap
201.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ANNX News
- 7 days ago - Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Annexon: With IGOS Study Completion, Pre-BLA Meeting In 1st Half 2025 On Deck - Seeking Alpha
- 15 days ago - Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting - GlobeNewsWire
- 20 days ago - Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting - GlobeNewsWire
- 7 weeks ago - Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones - GlobeNewsWire
- 2 months ago - Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Annexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual Meeting - GlobeNewsWire